Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GPhA Wants “Authorized” Generics Stopped; Will FDA Help?

Executive Summary

The Generic Pharmaceutical Association is seeking an end to the practice of "authorized" generics

You may also be interested in...



GPhA Seeks Change On Medicaid “Best Price” For “Authorized” Generics

The Generic Pharmaceutical Association's challenge to "authorized" generics includes pushing for a change in how the Medicaid "best price" for a branded product and its authorized generic are reported

GPhA Seeks Change On Medicaid “Best Price” For “Authorized” Generics

The Generic Pharmaceutical Association's challenge to "authorized" generics includes pushing for a change in how the Medicaid "best price" for a branded product and its authorized generic are reported

Mylan Takes “Authorized” Generics Fight To Congress, FTC, Courts

Mylan is taking its fight against "authorized" generics beyond FDA to Capitol Hill, the Federal Trade Commission and the federal courts

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel